Company Filing History:
Years Active: 1998
Title: Innovations by Bobby V Khan in Cardiovascular Treatment
Introduction
Bobby V Khan is a prominent inventor based in Dunwoody, GA (US), known for his significant contributions to the field of cardiovascular medicine. With a total of six patents to his name, Khan has focused on developing innovative treatments for atherosclerosis and other cardiovascular and inflammatory diseases.
Latest Patents
Khan's latest patents include a method for treating cardiovascular diseases and non-cardiovascular inflammatory diseases mediated by VCAM-1. This method involves the removal, decrease in concentration, or prevention of the formation of oxidized polyunsaturated fatty acids. Additionally, it interferes with a complex formed between a polyunsaturated fatty acid or an oxidized polyunsaturated fatty acid and a protein or peptide that mediates the expression of VCAM-1. Another aspect of his patent includes a method for suppressing the expression of a redox-sensitive gene or activating a gene that is suppressed through a redox-sensitive pathway. This involves administering an effective amount of a substance that prevents the oxidation of the oxidized signal, typically the oxidation of a polyunsaturated fatty acid.
Career Highlights
Bobby V Khan is affiliated with Emory University, where he continues to advance research in cardiovascular treatments. His work has garnered attention for its potential to significantly impact the management of cardiovascular diseases.
Collaborations
Khan has collaborated with notable colleagues, including Russell M Medford and R Wayne Alexander, to further enhance the research and development of innovative treatments in his field.
Conclusion
Bobby V Khan's contributions to cardiovascular medicine through his patents and collaborations highlight his commitment to advancing healthcare solutions. His innovative approaches have the potential to improve the lives of many individuals suffering from cardiovascular diseases.